This HTML5 document contains 144 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38862274
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 2017) artículu científicu espublizáu en 2017 wetenschappelijk artikel vitenskapelig artikkel სამეცნიერო სტატია научная статья tudományos cikk научни чланак artikulong pang-agham мақолаи илмӣ vetenskaplig artikel 2017年學術文章 2017年学术文章 bài báo khoa học мақолаи илмӣ vedecký článok articolo scientifico vitskapeleg artikkel 2017年学术文章 наукова стаття, опублікована у квітні 2017 מאמר מדעי научни чланак naučni članak article científic 2017年學術文章 գիտական հոդված บทความทางวิทยาศาสตร์ bilimsel makale 2017年学术文章 tieteellinen artikkeli wissenschaftlicher Artikel article scientific mokslinis straipsnis scientific article 2017 nî lūn-bûn videnskabelig artikel (udgivet 2017) 2017년 논문 artigo científico ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2017年学术文章 επιστημονικό άρθρο article scientifique (publié 2017) научна статия 2017年学术文章 artigo científico (publicado na 2017) scienca artikolo articol științific 2017年學術文章 artikull shkencor vědecký článek teaduslik artikkel سائنسی مضمون 2017年學術文章 2017年學術文章 مقالهٔ علمی artykuł naukowy 2017年學術文章 2017年の論文 artículo científico publicado en 2017 مقالة علمية نشرت بتاريخ 2-4-2017
p:P577
wds:Q38862274-661164B8-D057-43C5-83A6-9350A5912660
wdt:P577
2017-04-02T00:00:00Z
p:P407
wds:Q38862274-028E9E0B-886F-4639-9135-F2C6B64EE68E
wdt:P407
wd:Q1860
p:P2860
wds:Q38862274-45F2AD9F-6BE9-46AF-87FB-8B0A9239AE7C wds:Q38862274-5BED89E2-2F10-4D7A-AFBF-554A73516334 wds:Q38862274-0D5449FD-9E7B-474B-A4D0-5240FAFAFB67 wds:Q38862274-1788B63A-4270-4627-9FB6-A882BD589855 wds:Q38862274-D476C31D-4459-488A-BA89-9659A2B47D72 wds:Q38862274-E981425F-96AA-42AA-BEB9-C72EBFC53F7D wds:Q38862274-CD076E96-4C27-499A-99E4-EF7498517D78 wds:Q38862274-CDA0FEE0-598C-43A6-9F98-BF7B0E70E48A wds:Q38862274-D0886C47-48B6-4893-A8AF-7C6B8CBA2EFA wds:Q38862274-D3D919B4-9EFA-444D-B46D-2F32954718C2 wds:Q38862274-639594C2-5017-4C59-A23A-1E6C9D931ECD wds:Q38862274-8EE61D02-EB67-478F-A70F-BDA445B4012E wds:Q38862274-A8F631D0-23C7-4333-9235-8F1CAB7320AA wds:Q38862274-3D2BE6C5-8214-4C1A-9A2E-ACCD2EB72BB7
wdt:P2860
wd:Q34186228 wd:Q37421352 wd:Q41514274 wd:Q57252888 wd:Q45343563 wd:Q29614200 wd:Q39830413 wd:Q40695500 wd:Q37301072 wd:Q40515343 wd:Q36714127 wd:Q34054106 wd:Q37989837 wd:Q37419333
p:P2093
wds:Q38862274-0B374101-3785-4241-9BDA-D918041F3262 wds:Q38862274-B2B762E8-D899-4C39-874E-C4ED2191BBA2 wds:Q38862274-6AEB96D9-AEEF-4C1D-98A1-8D5E9293A949 wds:Q38862274-45289CC1-DC59-409B-86DF-A716127A3ADC wds:Q38862274-F698FB6D-F61A-48BD-B2DD-0263BAE6F84D wds:Q38862274-D93B6345-8134-456D-84CE-A33C4F848703 wds:Q38862274-C9CC41FD-603E-47DC-8BD2-128B136A8DB9
wdt:P2093
François Laliberté Craig Coleman Zhong Yuan Veronica Ashton Concetta Crivera Jeff Schein Patrick Lefebvre
rdfs:label
Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban
skos:prefLabel
Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban
schema:name
Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban
p:P50
wds:Q38862274-508B7992-A54C-4743-A537-26C41B5619D9
wdt:P50
wd:Q63021326
p:P1476
wds:Q38862274-F6AECC02-8FE1-4261-8684-FC67486096B9
wdt:P1476
Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban
p:P304
wds:Q38862274-ADF56041-0726-4B60-A9A5-0EE413316074
wdt:P304
1033-1043
p:P31
wds:Q38862274-355B6F2F-54B5-490D-B7F5-D4D58AF33DFF
wdt:P31
wd:Q13442814
p:P921
wds:Q38862274-BDAAE52D-4FD5-47BA-BA4D-0B0CEC0EF267 wds:Q38862274-FECAF6B9-2CC7-45EC-A677-D81B1B42CD2D wds:Q38862274-5B67AF3A-C819-4F70-A546-A06EA511AE71 wds:Q38862274-4170012D-BF14-4D89-B20B-8F2699F5F5F1
wdt:P921
wd:Q63279445 wd:Q215118 wd:Q815819 wd:Q414462
p:P698
wds:Q38862274-D7957C6D-2283-499E-8081-67D38BAA64B6
wdtn:P698
n11:28366075
wdt:P698
28366075
p:P1433
wds:Q38862274-602A3FC7-4804-41C5-B2E6-9931A436C798
wdt:P1433
wd:Q5195063
p:P433
wds:Q38862274-B909DB03-CA15-4360-BF7B-09FD6095E269
p:P478
wds:Q38862274-BFB5F8F1-F024-4659-94E4-D4CF1C84258B
wdt:P433
6
wdt:P478
33
p:P356
wds:Q38862274-C2B7E38F-7DA0-40CB-9F38-FD92C8DA2BE0
wdtn:P356
n8:03007995.2017.1297932
wdt:P356
10.1080/03007995.2017.1297932